Team Lead Writer

Medscape, PulsePoint, and WebMD introduce moments. September 15, 2026 September 15, 2026 /PRNewswire/ - Medscape, PulsePoint and WebMD today announced Moments, a real-time health engagement solution, composed of Medscape Moments and WebMD Moments, activated across the full media plan by PulsePoint. Medscape Moments detects clinical engagement as it happens on Medscape such as a physician reviewing a drug monograph, researching a condition, or running a query through Medscape AI. WebMD Moments detects consumer engagement as it happens on WebMD, such as symptom research or treatment comparisons. PulsePoint's Adaptive Optimization engine activates those first-party intent signals from both environments across the media plan, prioritizing delivery across the full audience toward moments of peak receptivity and readiness". Medscape Moments has on average produced a 150% lift in new prescriptions per exposed HCP versus HCPs not informed by Moments, and DTC optimization including WebMD signals, improved audience quality by 18%. "Every other vertical has been able to do something health marketing couldn't: time activation to real behavior. Receptivity isn't constant. A doctor reviewing a drug monograph the night before a patient encounter is in a different state than the same doctor a week later," said Parker Noren, SVP Product Strategy. "Moments captures that as it happens on Medscape and WebMD, and PulsePoint acts on it across the full media plan the same day, HCP and DTC. That's what turns broad reach into effective reach. And it held everywhere we ran it: clinician and consumer campaigns, rare disease and high-prevalence conditions. It changed what a health campaign is capable of." For years, the only way to sharpen targeting beyond reach was claims data, which arrives after the clinical decision it was meant to influence. Medscape Moments and WebMD Moments replace that lag with active intent signals for PulsePoint to act on at the moment of receptivity. Medscape Moments and WebMD Moments open to a broader set of pharmaceutical marketers in open beta beginning January 1, 2027. About Medscape Medscape is the leading source of clinical news, health information, and point-of-care tools for health care professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape AI is the first and only medical-grade generative AI platform that synthesizes peer-reviewed evidence, real-time medical news, and Medscape's expert-validated content in seconds, delivering clinically verified insights that healthcare professionals can trust. Built for global healthcare, Medscape AI is free to all 13+ million Medscape members and accessible in any language, in any country, and in any clinic. About PulsePoint PulsePoint, a division of Internet Brands, is an award-winning technology company that uses real-world data in real-time to optimize campaign performance and revolutionize health decision-making. Leveraging proprietary datasets and methodology, PulsePoint targets healthcare professionals and consumer populations with an unprecedented level of accuracy to deliver unparalleled results to the clients Pulsepoint serve. For more information, visit pulsepoint.com. About WebMD Health Corp. WebMD Health Corp., an Internet Brands company, is at the heart of the digital health revolution that is transforming the healthcare experience for consumers, patients, healthcare professionals, employers, health plans and health systems. Through public and private online portals, mobile platforms, and health-focused publications, WebMD delivers leading-edge content and digital services that enable and improve decision-making, support and motivate health actions, streamline and simplify the healthcare journey, and improve patient care. Press Contact: Alia Paavola [email protected]

The American Medical Association Friday named as its new CEO Dr. John J. Whyte a former chief. More medical officer at WebMD who also worked at the U.S. Department of Health and Humana Services and the U.S. Food and Drug Administration